Koers RegeneRx Biopharmaceuticals Inc OTC Bulletin Board
Aandelen
Farmaceutische producten
Omzet 2021 | 76,76K 71,52K | Omzet 2022 | 76,76K 71,52K | Marktkapitalisatie | 19,94 mln. 18,58 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -1 mln. -932K | Nettowinst (verlies) 2022 | -1 mln. -932K | EV/omzet 2021 | 298 x |
Nettoliquiditeiten 2021 | 66,69K 62,14K | Nettoschuld 2022 | 1,16 mln. 1,08 mln. | EV/omzet 2022 | 275 x |
K/w-verhouding 2021 |
-13,9
x | K/w-verhouding 2022 |
-11,5
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 55,86% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 86 | 13-05-82 | |
J. Finkelstein
CEO | Chief Executive Officer | 72 | 01-01-84 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
J. Finkelstein
CEO | Chief Executive Officer | 72 | 01-01-84 |
Founder | 86 | 13-05-82 | |
Joe McNay
BRD | Director/Board Member | 90 | 01-01-02 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+2,52% | 92,1 mld. | |
-3,16% | 37,92 mld. | |
-12,49% | 32,97 mld. | |
+74,97% | 27,92 mld. | |
-11,82% | 16,14 mld. | |
-0,16% | 14,1 mld. | |
-11,18% | 11,66 mld. | |
+171,57% | 10,29 mld. | |
-50,45% | 9,99 mld. |